The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities.
about
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsThe prognostic value of cardiac dysfunction assessed by bedside echocardiography in critically ill patients with COPD requiring mechanical ventilation: a study protocolPrognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.Bone marrow-derived cells contribute to fibrosis in the chronically failing heartNon-coding RNAs in cardiac hypertrophy.Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.Association of myocardial angiogenesis with structural and functional ventricular remodeling in aortic stenosis patients with normal ejection fractionIKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.Low birth weight activates the renin-angiotensin system, but limits cardiac angiogenesis in early postnatal life.N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.PET and MRI for the evaluation of regional myocardial perfusion and wall thickening after myocardial infarction.Differential microRNA Expression and Regulation in the Rat Model of Post-Infarction Heart Failure.Emerging role of liver X receptors in cardiac pathophysiology and heart failure.Galectin-3: A Link between Myocardial and Arterial Stiffening in Patients with Acute Decompensated Heart Failure?Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectorisPVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells.ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism.The emerging role of microRNAs in cardiac remodeling and heart failure.Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stressMicroRNA involvement in immune activation during heart failure.Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failurePET imaging of cardiac hypoxia: opportunities and challenges.Non-cardiomyocyte microRNAs in heart failure.Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technologyAlterations in atrial perfusion during atrial fibrillation.Genetic polymorphisms associated with heart failure: A literature review.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.New insights into mechanisms of cardioprotection mediated by thyroid hormones.From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipientsExercise leads to unfavourable cardiac remodelling and enhanced metabolic homeostasis in obese mice with cardiac and skeletal muscle autophagy deficiencyBone marrow-derived cells and their conditioned medium induce microvascular repair in uremic rats by stimulation of endogenous repair mechanisms.Age-related atrial fibrosis.Pressure overload induces early morphological changes in the heart.Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy.Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity.Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.Myocardial perfusion in patients with non-ischaemic systolic heart failure and type 2 diabetes: a cross-sectional study using Rubidium-82 PET/CT.
P2860
Q28087776-78D72459-E8E1-4D7D-95D3-54E9B3B649FEQ30588547-F8887AB4-1036-471E-ACD1-A9ABBAC51FE6Q33529398-10A0E4D8-43C2-4A20-8017-10E29FE9B4DAQ33745166-301201B2-1766-4DCA-BD3E-51945D6B8F1FQ33800147-B7DC76D0-2074-4C19-8F4A-FCFA4AFC80F1Q33838831-ECBAD003-DEF7-4BD9-AAA8-71730FD41B8DQ33896306-0291FEA5-6483-4C3F-9E5E-99813F7A4C6DQ34562186-66ABF353-D3DE-4FAC-9428-3CA3F9083EB9Q35363488-9640A41E-2454-462E-B58A-03DC7F082D54Q35665230-182800A2-FB88-4DF4-948F-605B4F0E82C3Q35928762-938885CE-8438-4579-8EE4-B1EE768FD02AQ36098660-4847B09F-C413-4880-A806-F49D44763090Q36322805-A598AD0D-637B-4D82-B90A-365E460F856EQ36611468-BCF321F6-A20D-4289-A27B-88B7D3F193F7Q36687489-41797A25-0700-4530-8567-50727A98BA55Q36995413-D837C167-44C9-4DF4-AD2E-67EA3C109112Q37315436-B31DCBB5-412A-4377-A41E-A6C9FCA3DC37Q37319218-742EC3DE-1204-4A17-986D-50C8578102C0Q37352122-731DC7B6-692D-4EA1-BCFE-7651C2373227Q37456901-EB529E0E-3F5D-46E4-B8D2-86F4ABE3B3D6Q37866669-39B294BE-D772-4FB3-9886-726568F90166Q37883418-83EDADBC-B85F-4E76-BCFF-C2CDD048BB81Q37904019-D6B10BA6-AE9C-4DB3-9566-0790282E1D55Q37969738-1F71121A-3455-44C0-A716-9C7237AE31F2Q38025390-611F38CE-2C73-4E1A-948D-E72FC1392416Q38120722-CF17CBB6-0610-4330-83D2-60BCD25BDF57Q38234147-DBA4AB38-6F61-4266-9BE0-454D1DAFD6C4Q38697467-16B0ABD9-0F96-4364-9DEE-CF69F233CA54Q38703115-E6494082-8838-4575-8B4F-54078CEEC36DQ39299996-500B060E-88AD-47BC-9E52-BB6EE56D025CQ39434474-076E3063-D0C8-474E-8702-EA10A5C31797Q39999470-9FE7C733-8C7F-4CBB-8862-73A00F498B35Q41368114-CCEF051B-73E0-4CE6-B70D-9675E0A45000Q41529629-9F1E44A0-94FD-457B-B492-6397AD2DA589Q41780081-CDF436DB-3373-4AD7-9844-1F52EFD39A9DQ41840219-2B928637-4913-4BBF-831D-A552B64C3C35Q42002347-A487DE7A-DD73-40F5-BF0E-BE6381EABB62Q42755181-CFA2C237-BD4A-49D0-A425-2514078C2549Q46877188-768984FC-A5CE-4817-9835-2BF164716A50Q47559357-9D6F12BE-775E-4E9C-A634-FA4BBF172B42
P2860
The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The imbalance between oxygen d ...... ular growth and abnormalities.
@ast
The imbalance between oxygen d ...... ular growth and abnormalities.
@en
type
label
The imbalance between oxygen d ...... ular growth and abnormalities.
@ast
The imbalance between oxygen d ...... ular growth and abnormalities.
@en
prefLabel
The imbalance between oxygen d ...... ular growth and abnormalities.
@ast
The imbalance between oxygen d ...... ular growth and abnormalities.
@en
P2093
P356
P1433
P1476
The imbalance between oxygen d ...... ular growth and abnormalities.
@en
P2093
Dirk J Van Veldhuisen
Rudolf A De Boer
Yigal M Pinto
P304
P356
10.1038/SJ.MN.7800188
P577
2003-04-01T00:00:00Z